BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26798408)

  • 1. DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder.
    Walker RM; Christoforou AN; McCartney DL; Morris SW; Kennedy NA; Morten P; Anderson SM; Torrance HS; Macdonald A; Sussmann JE; Whalley HC; Blackwood DH; McIntosh AM; Porteous DJ; Evans KL
    Clin Epigenetics; 2016; 8():5. PubMed ID: 26798408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary assessment of pre-morbid DNA methylation in individuals at high genetic risk of mood disorders.
    Walker RM; Sussmann JE; Whalley HC; Ryan NM; Porteous DJ; McIntosh AM; Evans KL
    Bipolar Disord; 2016 Aug; 18(5):410-22. PubMed ID: 27440233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypomethylation of Synapsin II CpG islands associates with increased gene expression in bipolar disorder and major depression.
    Cruceanu C; Kutsarova E; Chen ES; Checknita DR; Nagy C; Lopez JP; Alda M; Rouleau GA; Turecki G
    BMC Psychiatry; 2016 Aug; 16(1):286. PubMed ID: 27515700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients.
    Dell'Osso B; D'Addario C; Carlotta Palazzo M; Benatti B; Camuri G; Galimberti D; Fenoglio C; Scarpini E; Di Francesco A; Maccarrone M; Altamura AC
    J Affect Disord; 2014 Sep; 166():330-3. PubMed ID: 25012449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder.
    Zeng Y; Navarro P; Shirali M; Howard DM; Adams MJ; Hall LS; Clarke TK; Thomson PA; Smith BH; Murray A; Padmanabhan S; Hayward C; Boutin T; MacIntyre DJ; Lewis CM; Wray NR; Mehta D; Penninx BWJH; Milaneschi Y; Baune BT; Air T; Hottenga JJ; Mbarek H; Castelao E; Pistis G; Schulze TG; Streit F; Forstner AJ; Byrne EM; Martin NG; Breen G; Müller-Myhsok B; Lucae S; Kloiber S; Domenici E; ; Deary IJ; Porteous DJ; Haley CS; McIntosh AM
    Biol Psychiatry; 2017 Sep; 82(5):312-321. PubMed ID: 28153336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide haplotype-based association analysis of major depressive disorder in Generation Scotland and UK Biobank.
    Howard DM; Hall LS; Hafferty JD; Zeng Y; Adams MJ; Clarke TK; Porteous DJ; Nagy R; Hayward C; Smith BH; Murray AD; Ryan NM; Evans KL; Haley CS; Deary IJ; Thomson PA; McIntosh AM
    Transl Psychiatry; 2017 Nov; 7(11):1263. PubMed ID: 29187746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
    Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
    Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic signatures relating to disease-associated genotypic burden in familial risk of bipolar disorder.
    Hesam-Shariati S; Overs BJ; Roberts G; Toma C; Watkeys OJ; Green MJ; Pierce KD; Edenberg HJ; Wilcox HC; Stapp EK; McInnis MG; Hulvershorn LA; Nurnberger JI; Schofield PR; Mitchell PB; Fullerton JM
    Transl Psychiatry; 2022 Aug; 12(1):310. PubMed ID: 35922419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype phasing of a bipolar disorder pedigree revealed rare multiple mutations of SPOCD1 gene in the 1p36-35 susceptibility locus.
    Takamatsu G; Yanagi K; Koganebuchi K; Yoshida F; Lee JS; Toyama K; Hattori K; Katagiri C; Kondo T; Kunugi H; Kimura R; Kaname T; Matsushita M
    J Affect Disord; 2022 Aug; 310():96-105. PubMed ID: 35504398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls.
    Coleman JRI; Gaspar HA; Bryois J; ; ; Breen G
    Biol Psychiatry; 2020 Jul; 88(2):169-184. PubMed ID: 31926635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP5 polymorphism is associated with major depression but not with bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Narozna B; Rajewska-Rager A; Wilkosc M; Zaremba D; Maciukiewicz M; Twarowska-Hauser J
    J Affect Disord; 2014 Aug; 164():33-7. PubMed ID: 24856550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia.
    McGrath LM; Cornelis MC; Lee PH; Robinson EB; Duncan LE; Barnett JH; Huang J; Gerber G; Sklar P; Sullivan P; Perlis RH; Smoller JW
    Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):779-88. PubMed ID: 24039173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder.
    Schröter K; Brum M; Brunkhorst-Kanaan N; Tole F; Ziegler C; Domschke K; Reif A; Kittel-Schneider S
    Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):169-181. PubMed ID: 30929061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.
    Chang SH; Gao L; Li Z; Zhang WN; Du Y; Wang J
    Biol Psychiatry; 2013 Nov; 74(10):727-33. PubMed ID: 23764453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased DNA methylation at promoters and gene-specific neuronal hypermethylation in the prefrontal cortex of patients with bipolar disorder.
    Bundo M; Ueda J; Nakachi Y; Kasai K; Kato T; Iwamoto K
    Mol Psychiatry; 2021 Jul; 26(7):3407-3418. PubMed ID: 33875800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution.
    Ferentinos P; Rivera M; Ising M; Spain SL; Cohen-Woods S; Butler AW; Craddock N; Owen MJ; Korszun A; Jones L; Jones I; Gill M; Rice JP; Maier W; Mors O; Rietschel M; Lucae S; Binder EB; Preisig M; Tozzi F; Muglia P; Breen G; Craig IW; Farmer AE; Müller-Myhsok B; McGuffin P; Lewis CM
    J Affect Disord; 2014 Feb; 155():81-9. PubMed ID: 24215895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms.
    Vereczkei A; Abdul-Rahman O; Halmai Z; Nagy G; Szekely A; Somogyi A; Faludi G; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():207-216. PubMed ID: 30664971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminating bipolar depression from major depressive disorder with polygenic risk scores.
    Liebers DT; Pirooznia M; Ganna A; ; Goes FS
    Psychol Med; 2021 Jul; 51(9):1451-1458. PubMed ID: 32063240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.
    Amare AT; Vaez A; Hsu YH; Direk N; Kamali Z; Howard DM; McIntosh AM; Tiemeier H; Bültmann U; Snieder H; Hartman CA
    Mol Psychiatry; 2020 Jul; 25(7):1420-1429. PubMed ID: 30626913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder.
    Goud Alladi C; Etain B; Bellivier F; Marie-Claire C
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.